US2009314664A1PendingUtilityA1
Pack Containing Pharmaceutical Administration Forms
Est. expiryAug 3, 2026(~0 yrs left)· nominal 20-yr term from priority
B65D 81/266B65D 83/0463B65D 77/04B65D 75/36B65D 81/26B65D 83/04
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a pack comprising a container ( 2 ) and solid pharmaceutical administration forms packed in blister packs ( 4 ).
Claims
exact text as granted — not AI-modified1 . Pack comprising a resealable container in whose inside wall(s) at least one channel former is embedded together with at least one absorbent, at least over part of the area, and at least one blister pack containing one or more solid pharmaceutical administration forms, where the blister pack(s) is (are) contained in the container.
2 . Pack according to claim 1 , characterised in that the container has a cuboid basic shape.
3 . Pack according to claim 1 , characterised in that the container contains, as absorbent, a desiccant which binds moisture by physical adsorption.
4 . Pack according to claim 3 , characterised in that the desiccant is a molecular sieve or silica gel.
5 . Pack according to claim 1 , characterised in that the cavity and/or cover sheet or film of the blister pack(s) contained therein consists of polyvinyl chloride (PVC), polyvinylidene chloride (PVDC), high-density polyethylene (HDPE), polypropylene (PP), polyethylene terephthalate (PET), polycarbonate, cycloolefin copolymer (COC), polychlorotrifluoroethylene (PCTFE), or of composite sheets or films made from these materials, such as PVC/PVDC, PVC/HDPE, PVC/PCTFE, PP/COC, PVC/COC/PVDC.
6 . Pack according to claim 5 , characterised in that as cavity and/or cover sheet or film consist of PVC, PP or PET.
7 . Pack according to claim 1 , characterised in that the blister pack(s) contained in the pack is contain at least one hole in each cavity containing a solid pharmaceutical administration form.
8 . Pack according to claim 7 , characterised in that a plurality of holes are pre-sent as perforation in each cavity.
9 . Pack according to claim 8 , characterised in that the perforation is a micro-perforation.
10 . Pack according to claim 7 , characterised in that the hole, holes, perforation or microperforation is (are) in each case introduced in the cover sheet or film.
11 . Pack according to claim 1 , characterised in that the solid pharmaceutical administration form(s) contained in the blister pack(s) contained therein are tablets, dragees, capsules, granules, suppositories, pellets and/or powders.
12 . Process for the production of the pack according to claim 1 , characterised in that the solid pharmaceutical administration forms is introduced into a blister pack and sealed, and the sealed blister pack is subsequently introduced into a container which [lacuna] of a tightly sealable container in whose inside wall(s) at least one channel former is embedded together with at least one absorbent, at least over part of the area.
13 . Method for increasing the shelf life of solid pharmaceutical administration forms, characterised in that the latter is introduced into a blister pack and sealed, and the sealed blister pack is subsequently introduced into a container which consists of a tightly sealable container in whose inside wall(s) at least one channel former is embedded together with at least one absorbent, at least over part of the area.Join the waitlist — get patent alerts
Track US2009314664A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.